Latest Breaking News On - ஜெர்மனி பிப்ரவரி - Page 1 : comparemela.com

Bayer boosts drug pipeline with Vividion buy, lifts outlook FILE PHOTO: The logo of Bayer AG is seen in a showroom of the German drugmaker where the annual results news conference takes place in Leverkusen, Germany February 27, 2020. REUTERS/Wolfgang Rattay/File Photo August 5, 2021 By Christoph Steitz FRANKFURT (Reuters) -Bayer on Thursday boosted its drug pipeline with a $2 billion takeover and lifted its outlook for 2021 after sales of prescription medicines recovered from restrictions related to the COVID-19 pandemic. Bayer now expects sales of 43 billion euros ($50.9 billion) this year, up from 41 billion earlier. Core earnings (EBITDA) before special items are seen at 10.6 billion to 10.9 billion euros, compared with 10.5 billion to 10.8 billion previously.

Christoph steitzeditingTomasz janowskiWerner baumannChristoph steitzBayer agGermany februaryVividion therapeuticsChief executive werner baumannவெர்னர் பாமன்கிறிஸ்டோஃப் ஸ்டேத்ஜுஜெர்மனி பிப்ரவரிதலைமை நிர்வாகி வெர்னர் பாமன்